← Leaderboards
Christopher Edward Mason
Columbia University Health Sciences
$16,419,065
Attributed
$33,658,163
Total exposure
13
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2011–25$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,058,162 · 14
By mechanism
R01$26,231,409 · 8
U54$5,260,820 · 2
U01$5,188,351 · 1
R21$867,883 · 2
P01$509,699 · 1
Top collaborators
- Margaret Elizabeth Ross8 shared
- Ana Navas-Acien7 shared
- Andrea Baccarelli6 shared
- Julie Beth Herbstman6 shared
- Darshana Dadhania5 shared
- Iwijn De Vlaminck5 shared
- Christopher Y Park5 shared
- Michael Richard Green4 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Medini K Annavajhala$1,283,298
- Srikumar P Chellappan$11,182,462
Others in their field
Top investigators on “Genetic Transcription”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$69,905,031
- Bing Ren · Ludwig Institute For Cancer Research$61,600,123
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$54,253,356
- Richard Gibbs · Baylor College Of Medicine$53,550,246
- John A Tainer · Scripps Research Institute$51,251,962
- Deepak Srivastava · J. David Gladstone Institutes$50,027,907
Research focus
Genetic TranscriptionGenesCohortResponseSamplingBiologicalAffectCellsPathway InteractionsGene ExpressionMolecularBaseFutureTissuesModificationGeneticLifeMediatingProteinsDesignRna SplicingAdultBloodLink
Grant awards (54)
VAST Center: Viromes Across Space(s) and Time$4,399,999
U54 · FY2025 · AG
VAST Center: Viromes Across Space(s) and Time$860,821
U54 · FY2025 · AG · contact PI
BAF complex deregulation in lymphoma$686,111
R01 · FY2025 · CA
Prenatal Traffic-Related Air Pollutants, Placental Epitranscriptomics, and Child Cognition$626,463
R01 · FY2025 · ES
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.$580,180
R01 · FY2025 · ES
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.$558,135
R01 · FY2025 · ES
Biostatistics and Computational Biology (BCB) Core$246,371
P01 · FY2025 · CA · contact PI
Prenatal Traffic-Related Air Pollutants, Placental Epitranscriptomics, and Child Cognition$69,457
R01 · FY2025 · ES
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$662,916
R01 · FY2024 · CA
BAF complex deregulation in lymphoma$651,802
R01 · FY2024 · CA
Prenatal Traffic-Related Air Pollutants, Placental Epitranscriptomics, and Child Cognition$634,468
R01 · FY2024 · ES
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.$616,651
R01 · FY2024 · ES
Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation$542,073
R01 · FY2024 · AI
Biostatistics and Computational Biology (BCB) Core$263,328
P01 · FY2024 · CA · contact PI
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.$83,049
R01 · FY2024 · ES
Assessing effects of air pollution exposure on trophoblast cell mRNA and EV miRNA expression.$34,729
R01 · FY2024 · ES
Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation$701,043
R01 · FY2023 · AI
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$685,543
R01 · FY2023 · CA
BAF complex deregulation in lymphoma$672,389
R01 · FY2023 · CA
Prenatal Traffic-Related Air Pollutants, Placental Epitranscriptomics, and Child Cognition$645,199
R01 · FY2023 · ES
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.$622,519
R01 · FY2023 · ES
Development and Proof-of-Concept Implementation of the South Florida Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure$2,341,239
U01 · FY2022 · DA
Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation$728,095
R01 · FY2022 · AI
BAF complex deregulation in lymphoma$701,610
R01 · FY2022 · CA
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$688,759
R01 · FY2022 · CA
Prenatal Traffic-Related Air Pollutants, Placental Epitranscriptomics, and Child Cognition$684,328
R01 · FY2022 · ES
The Spatiotemporal Landscape of the Human Brain Epitranscriptome$649,352
R01 · FY2022 · MH · contact PI
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.$644,088
R01 · FY2022 · ES
Supplement for MINI point-of-use device$170,248
U01 · FY2022 · DA
Development and Proof-of-Concept Implementation of the South Florida Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure$2,676,864
U01 · FY2021 · DA
Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation$734,706
R01 · FY2021 · AI
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$704,849
R01 · FY2021 · CA
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.$684,582
R01 · FY2021 · ES
The Spatiotemporal Landscape of the Human Brain Epitranscriptome$654,227
R01 · FY2021 · MH · contact PI
Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation$740,764
R01 · FY2020 · AI
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$740,279
R01 · FY2020 · CA
The Spatiotemporal Landscape of the Human Brain Epitranscriptome$658,960
R01 · FY2020 · MH · contact PI
The Spatiotemporal Landscape of the Human Brain Epitranscriptome$663,556
R01 · FY2019 · MH · contact PI
The Spatiotemporal Landscape of the Human Brain Epitranscriptome$685,392
R01 · FY2018 · MH · contact PI
Mapping the RNA modification N6-methyladenosine during Zika virus infection$205,313
R21 · FY2018 · AI · contact PI
Mapping the RNA modification N6-methyladenosine during Zika virus infection$263,750
R21 · FY2017 · AI · contact PI
Epigenome Interactions in Complex Neurogenetic Disorders$877,497
R01 · FY2015 · NS
Epigenome Interactions in Complex Neurogenetic Disorders$100,000
R01 · FY2015 · NS
Epigenome Interactions in Complex Neurogenetic Disorders$941,819
R01 · FY2014 · NS
Study of Neural Tube Defects Etiology: Genome and Exposome$339,816
R01 · FY2014 · ES
Defining molecular biomarkers for CDK4/6-based cancer therapy by RNA sequencing$178,275
R21 · FY2014 · CA
Epigenome Interactions in Complex Neurogenetic Disorders$1,301,838
R01 · FY2013 · NS
Study of Neural Tube Defects Etiology: Genome and Exposome$338,344
R01 · FY2013 · ES
Defining molecular biomarkers for CDK4/6-based cancer therapy by RNA sequencing$220,545
R21 · FY2013 · CA
Epigenome Interactions in Complex Neurogenetic Disorders$1,219,985
R01 · FY2012 · NS
Study of Neural Tube Defects Etiology: Genome and Exposome$359,938
R01 · FY2012 · ES
Epigenome Interactions in Complex Neurogenetic Disorders$79,369
R01 · FY2012 · NS
Epigenome Interactions in Complex Neurogenetic Disorders$49,798
R01 · FY2012 · NS
Epigenome Interactions in Complex Neurogenetic Disorders$1,186,731
R01 · FY2011 · NS